Journal Article

Long‐term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography

Reika Tanaka, Takatoshi Kakuta, Tomotaka Fujisaki, Shinichi Tanaka, Hideto Sakai, Kiyoshi Kurokawa and Akira Saito

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 18, issue suppl_3, pages iii58-iii61
Published in print June 2003 | ISSN: 0931-0509
Published online June 2003 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/gfg1015
Long‐term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography

Show Summary Details

Preview

Background. Secondary hyperparathyroidism (2HPT) is one of the most important complications in chronic dialysis (CD) patients. Percutaneous ethanol injection therapy (PEIT) of the parathyroid glands was introduced initially as an alternative treatment to parathyroidectomy and, with the technical progress of parathyroid imaging, it has now become a useful adjunct to medical therapy. The present study examined the possiblity of maintaining parathyroid function in the long term (3 years) after PEIT.

Method. PEIT, guided by power‐Doppler flow mapping, was performed in 33 CD patients with severe 2HPT, and all glands >5.0 mm in diameter were destroyed.

Results. All patients showed a decline in the serum intact parathyroid hormone (i‐PTH) concentration, on average from 695.5 to 248.0 pg/ml, after 1 year. After 3 years, the i‐PTH concentration was controlled at <300 pg/ml in 85% of patients. The mean serum alkaline phosphatase (ALP) concentration also decreased from 322.7 to 154.4 IU/l after 1 year. In 76% of patients, ALP was maintained within the normal range (between 76 and 260 IU/l) at 3 years. Patients were classified into four groups according to the number of parathyroid glands detected by ultrasonography: one gland in group 1, two in group 2, three in group 3, and four in group 4. At 3 years after PEIT, i‐PTH was controlled at <300 pg/ml in 100, 79, 83 and 82% of the patients in groups 1–4, respectively.

Conclusions. It was possible to maintain long‐term parathyroid function after PEIT in patients with 2HPT by using medical therapy, such as oral calcitriol pulse therapy and additional PEIT.

Keywords: dialysis; ethanol injection; parathyroid hormone; renal failure; secondary hyperparathyroidism

Journal Article.  2098 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.